Savage Robert G.
SEC-identified person · CIK 1232506 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Kalobios Pharmaceuticals INC KBIOQ | Director | filed 2018 - 2020 |
| Depomed INC DEPO | Director | filed 2016 - 2016 |
| Medicines CO /DE MDCO | Director | filed 2006 - 2016 |
| Immune Pharmaceuticals INC IMNPQ | Director | filed 2006 - 2013 |
| Medworth Acquisition Corp. MWRX | Director | filed 2013 - 2013 |
| Savient Pharmaceuticals INC SVNT | Director | filed 2012 - 2012 |
| Noven Pharmaceuticals INC NOWN | Director | filed 2006 - 2009 |
| Panacos Pharmaceuticals, INC. PANC | Director | filed 2007 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.